BioCentury
ARTICLE | Distillery Therapeutics

Inhibiting IL-33-driven inflammation to treat brain cancer

October 28, 2020 8:15 PM UTC

DISEASE CATEGORY: Cancer

INDICATION: Brain cancer...

BCIQ Company Profiles

University of Calgary